MedPath

Text2Breathe: Enhance Parent Communication to Reduce Pediatric Asthma Disparities

Not Applicable
Completed
Conditions
Asthma
Registration Number
NCT03032159
Lead Sponsor
Seattle Children's Hospital
Brief Summary

Text2Breathe (T2B) is a randomized controlled trial aimed at improving communication between parents and their children's' primary care providers about asthma. The overarching goal of this study is to reduce disparities among a population with high rates of pediatric asthma morbidity. The investigators are testing the efficacy of a short message service (SMS)-enhanced health communication (HC) intervention ("Text2Breathe") designed to equip urban, low-income parents with tools for communicating effectively with their children's primary care provider (PCP).

Detailed Description

Potentially eligible participants are approached and screened in person during an admission of their child to the emergency department for asthma care. Those participants randomized to the intervention will receive additional education on effective communication with their child's primary care provider (PCP). These participants will also receive educational text messages for three months after their initial visit. Text messages will include education on effectively communicating with their child's provider and general asthma information. Both the control group and intervention group will receive text message reminders to schedule regular follow up visits with their PCP and get an annual flu shot. Both groups will be contacted for follow up phone interviews at 3, 6, 12, 18 and 24 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
221
Inclusion Criteria
  • Unlimited text messaging

Is the parent of child who is:

  • Receiving asthma related care in the emergency department
  • 2-12 years old inclusive
  • Medicaid insured (no Private insurance)
  • Physician diagnosed asthma for at least 12 months
Exclusion Criteria

Is the parent of child who:

  • Has seen a pulmonary or allergy sub-specialist more than once in the last 6 months
  • Has seen a sub-specialist (not pulmonary or allergy) more than once in the last 12 months
  • Has been hospitalized for more than 30 days
  • Is currently enrolled in another asthma program or study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Emergency Department Visits for Asthma Care12 months

Number of emergency department visits for asthma care

Secondary Outcome Measures
NameTimeMethod
Asthma Morbidity12 months

Asthma morbidity measured as the number of days (or nights) of impairment.

Trial Locations

Locations (2)

Seattle Children's

🇺🇸

Seattle, Washington, United States

Mary Bridge Children's Hospital at Multi Care Health System

🇺🇸

Tacoma, Washington, United States

Seattle Children's
🇺🇸Seattle, Washington, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.